SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-013632
Filing Date
2020-11-12
Accepted
2020-11-12 09:10:27
Documents
59
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q btai-20200930x10q.htm 10-Q 1321170
2 EX-10.1 btai-20200930ex1018d184a.htm EX-10.1 98256
3 EX-31.1 btai-20200930ex3110232e9.htm EX-31.1 17924
4 EX-31.2 btai-20200930ex3122b3a80.htm EX-31.2 17024
5 EX-32.1 btai-20200930ex321291878.htm EX-32.1 10390
6 EX-32.2 btai-20200930ex3225a06f5.htm EX-32.2 8758
7 GRAPHIC btai-20200930ex1018d184a003.jpg GRAPHIC 78585
8 GRAPHIC btai-20200930x10q006.jpg GRAPHIC 58762
  Complete submission text file 0001558370-20-013632.txt   4374241

Data Files

Seq Description Document Type Size
9 EX-101.INS btai-20200930.xml EX-101.INS 632760
10 EX-101.SCH btai-20200930.xsd EX-101.SCH 33328
11 EX-101.CAL btai-20200930_cal.xml EX-101.CAL 31794
12 EX-101.DEF btai-20200930_def.xml EX-101.DEF 95414
13 EX-101.LAB btai-20200930_lab.xml EX-101.LAB 309314
14 EX-101.PRE btai-20200930_pre.xml EX-101.PRE 219213
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Filer) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38410 | Film No.: 201303846
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences